Category: Digital Materials

Search Medicilon

Preclinical CRO

【BRIDGE】Medicilon XDC Innovation Forum · Seoul 2026

Preclinical CRO

World’s First Phase III Positive B7-H3 ADC: Medicilon Congratulates MediLink Therapeutics on NDA Acceptance of Icontamrotamab

Preclinical CRO

Medicilon Webinar | IND-enabling Toxicity Studies, CTD Documentation and Translational Cardiac Risk Assessment

Contact Medicilon

Name(Required)
Address(Required)